COMMUNIQUÉS West-GlobeNewswire

-
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
05/02/2019 -
Rockwell Medical, Inc. to Present at 2019 BIO CEO & Investor Conference
05/02/2019 -
Sientra Announces miraDry Leadership Transition
05/02/2019 -
ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019
05/02/2019 -
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2018 Financial Results on February 26
05/02/2019 -
Globus Medical Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call
05/02/2019 -
AIT Therapeutics Schedules Fiscal Third Quarter 2019 Financial Results Conference Call and Webcast
05/02/2019 -
aTyr Pharma to Present at the BIO CEO & Investor Conference
05/02/2019 -
Paratek Pharmaceuticals Launches NUZYRA™ (Omadacycline) in the United States
05/02/2019 -
Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results
05/02/2019 -
Emblem Corp. Announces Receipt of Interim Court Order and Mailing of Meeting Materials Related to its Special Meeting of Shareholders and Proposed Arrangement with Aleafia Health Inc.
05/02/2019 -
Cerner Reports Fourth Quarter and Full Year 2018 Results and Announces Plan to Initiate Quarterly Cash Dividend
05/02/2019 -
Amicus Therapeutics Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months at 15th Annual WORLDSymposium™
05/02/2019 -
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/02/2019 -
Bone Therapeutics SA to present at the Annual Meeting of the Orthopaedic Research Society (ORS)
05/02/2019 -
Agility Health Announces Corporate Update and Trading Resumption
05/02/2019 -
Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia
05/02/2019 -
Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives
05/02/2019 -
Healthwise Announces Dr. Daniel Meltzer as Chief Medical Officer
05/02/2019
Pages